Eradicane 6.7-E

SECTION 2: Hazards identification

Physical Properties Appearance: Amber liquid Odor: Aromatic Symptoms of Acute Exposure Laboratory tests in animals have shown that exposure to the active ingredient in this product, followed by ingestion of alcohol, may cause an adverse reaction, including low blood "pressure, rapid heart beat, and flushing of the skin. Consumption of alcohol during and after exposure to this product should be avoided. This product is a cholinesterase inhibitor. Severe cases of cholinesterase inhibition may lead to convulsions, pulmonary edema, respiratory failure, and death. Symptoms of cholinesterase inhibition may include salivation, tearing, sweating, muscle twitching, tremors, incoordination, headache, dizziness, nausea, cramps, and diarrhea.

Principle Routes of Exposure

The principal routes of exposure are skin contact with the product and inhalation of its mists or vapors. Medical Conditions Likely to be Aggravated by Exposure Thiocarbamates have been shown in laboratory animals to cause a disulfiram (Antabuse®) –type reaction in combination with alcohol. Hazardous Decomposition Products Combustion products: Toxic materials Unusual Fire, Explosion, and Reactivity Hazards This material will support combustion and may decompose under fire conditions to give off toxic materials.